Enterobacter cloacae strain 96-3 nitroreductase (NR) is a homodimeric flavoenzyme that catalyzes the pyridine nucleotide-dependent four-electron reduction of a variety of nitroaromatic compounds, including the explosives TNT (2,4,6-trinitrotoluene), RDX (1,3,5-trinitro-1,3,5-triazine), tetryl (2,4,6-trinitrophenyl-N-methylnitramine), and pentryl (2,4,6-trinitrophenyl-N-nitroaminoethylnitrate). The enzyme was initially characterized by Bryant et al. from a strain of Enterobacter that had been isolated from a weapons dump in La Jolla, CA. The enzyme displays a catalytic efficiency for nitroreduction at least 10-fold higher than that of several highly homologous bacterial nitroreductases and has long been thought to have evolved to be a more efficient nitroreductase due to the high nitroaromatic compound concentrations in its environment. We report the cloning and biochemical characterization of a nitroreductase gene from a clinical isolate of Enterobacter cloacae, a strain that presumably had not encountered high concentrations of nitroaromatics. The new enzyme, which we term retro-nitroreductase, had an amino acid sequence 96.7% identical to NR, and most differences are relatively conservative. The catalytic efficiency of the new enzyme is twofold less than that of NR for the oxidation of NADH and is not significantly different from the value observed for NR for the reduction of dinitrobenzyl alcohol. We conclude that NR has not significantly evolved to be a more efficient nitroreductase as a result of its environment, and the relatively high catalytic activity of the enzyme is a general property of Enterobacter cloacae nitroreductases. Antioxid. Redox Signal. 3,[747][748][749][750][751][752][753][754][755] 747
INTRODUCTION

E
NTEROBACTER CLOACAE strain 96-3 nitroreductase (NR) catalyzes the NAD(P)H-dependent reduction of nitroaromatic compounds, riboflavin derivatives, and quinones using a tightly bound flavin mononucleotide (FMN) cofactor (3, 14, 23) . Strain 96-3 was originally isolated from a weapons storage facility by Donovan et al. (7) and selected from a pool of 493 isolates for its superior ability to rapidly degrade nitroaromatic compounds. The enzyme was cloned and characterized by Bryant et al. (4) and is now known to be a member of a larger family of proteins found in bacteria and archea. Homologues of NR (28) have been implicated in drug resistance in Helicobacter pylori and several Clostridium species (9, 22) and herbicide resistance in the cyanobacterium Synechocystis sp. PCC 6803 (8) .
Nitroreductases have been traditionally separated into two classes based on their sensitivity to dissolved oxygen: Type I nitroreductases catalyze the oxygen-insensitive two-electron reduction of nitroaromatic compounds using NADH (b-nicotinamide adenine dinucleotide, reduced form) or NADPH (b-nicotinamide adenine dinucleotide phosphate, reduced form), whereas type II nitroreductases catalyze the oxygen-sensitive one-electron reduction of aryl nitro compounds utilizing a large variety of reducing equivalents (see Fig. 1 ) (21). Bryant and DeLuca have shown NR to be a type I nitroreductase (3) , and the NADH oxidase activity of NR has since been determined to be very low, having a k cat of 0.11 s 21 in the presence of saturating NADH (14) . The E. coli homologue of NR has been shown to be a member of the soxRS regulon and contributes to bacterial defense against oxidative stress by minimizing the redox cycling caused by the one-electron reduction of nitro compounds (18) . Consistent with these findings, the semiquinone oxidation state of the FMN cofactor of NR is completely suppressed (Koder and Miller, unpublished data) , and when exposed to oxygen, the reduced enzyme has been shown to produce twoelectron-reduced hydrogen peroxide and not one-electron-reduced superoxide, the parent of the most damaging radical oxygen species, hydroxyl radical (19) .
Seibner examined the activities of several members of the NR gene family using a variety of substrates. It was found that, although the quinone reductase activities of all the enzymes were comparable, NR displayed an , 10-fold higher activity for nitroaromatic compounds than the other enzymes (23). This finding, the unusual origin of Enterobacter cloacae strain 96-3, and the enhanced expression of NR in the presence of nitroaryl compounds (3) have led to the hypothesis that the high nitroreductase activity of NR reflects selection for the ability to metabolize nitrated aromatics (5, 7, 11, 14) .
As a test of this hypothesis, we report the gene sequence, purification, and characterization of a nitroreductase from a clinical isolate of Enterobacter cloacae (1), a strain that presumably has not encountered high concentrations of nitroaromatic compounds and thus should not have evolved a more efficient nitroreductase enzyme as a response to selective pressure. We refer to the enzyme as retro-nitroreductase, or RNR, to denote its purported "pre-evolutionary" relationship with NR. Our compari- son of the two enzymes' amino acid sequences and nitroreductase activities argues against this evolutionary hypothesis. 13047, CDC no. 442-68). Other common organisms and vectors were from laboratory stocks. Automated DNA sequencing was performed by the Johns Hopkins DNA analysis CORE facility. NR was purified as previously described (13) .
MATERIALS AND METHODS
General
Microbiology
Lyophilized Enterobacter cloacae were suspended in 5 ml of Luria-Bertini broth (LB) and incubated overnight at 37°C. This culture was used to inoculate 1 L of LB, which was grown at 37°C until the optical density at 600 nm had reached 1.0. The bacteria were collected by centrifugation, and genomic DNA was isolated using the method of Silhavy et al. (24) with the modification that three prolonged phenol chloroform extractions were necessary to remove bacterial proteins completely.
Cloning
The RNR gene was sequenced using a twostage method (see Fig. 2 ) to accommodate the
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The sequence between the most conserved regions in the NR gene family (indicated by thick bars in the genomic DNA sequence at top) was PCR-amplified using degenerate oligonucleotide primers 1 and 2. The product of this reaction was gel-purified and ligated into the EcoRV site of pT7Blue, and the amplified plasmid was sequenced. (2) This interior sequence was used as a template for multiplex restriction site (mrs) PCR to determine the sequence of the regions flanking the gene fragment determined above: Using genomic DNA as a template, oligonucleotide primers 3 (forward) or 6 (reverse) and a mixture of oligonucleotides corresponding to the restriction sites BamHI, EcoRI, Sau3AI, and TaqI (indicated by open arrows) were used to PCR-amplify gene fragments containing sequences complementary to both the restriction sites and the primers. These products were purified and served as the template in a nested PCR using the same restriction site oligonucleotides and primers 4 or 7. Reaction products were purified and sequenced directly using primers 5 or 8.
fact that we had no prior knowledge of the gene sequence. First, oligonucleotide primers 1 (CGCGCGCCATGGCAGCCGTGGCAYTT) and 2 (CGCGCGCTCAGAGGTCRAAAC-CTTCYATKGG) were synthesized with the indicated degeneracy (Y 5 C/T, R 5 G/A, K 5 G/T) to be complementary to two regions highly conserved in NR and its homologues: QPWHF (residues 44-48) and PIEGFD (residues 162-167). The region between these two primers was polymerase chain reaction (PCR)-amplified using the Elongase amplification system (Life Technologies, Rockville, MD, U.S.A.). Appropriately sized products were purified by agarose gel electrophoresis, blunted with Klenow fragment, ligated into the EcoRV restriction site of plasmid pT7Blue (Novagen, Madison, WI, U.S.A.) and transformed into E. coli strain DH5a. Successful transformants, identified using blue/white colony screening on LB-agar plates containing 70 mg/ml 5-
, and 25 mg/ml kanamycin, were grown overnight in 100 ml of LB containing 25 mg/ml kanamycin. Plasmid DNA was isolated using the plasmid midi kit from Qiagen (Valencia, CA, U.S.A.), and both strands of the insert were sequenced. This entire procedure was repeated three times to eliminate amplification and sequencing errors.
The sequences of the regions flanking the above fragment of the RNR gene were obtained using multiplex restriction site PCR (27) . Oligonucleotide primers 3-8 were designed complementary to the interior sequence of RNR oriented in each direction (see Fig. 2 : 3 5 GCC-AGCACTGAGGAAGGTAAAG, 4 5 ACTTAC-GTGTTCAACGAACCCAAA, 5 5 CACATGC-ACCGCGTGGATGTG, 6 5 CAGATCCACGC-GGTGCATGTCGG, 7 5 CTCAAGCCACGCA-TCGTCCATGGC, 8 5 CACGCGCGCTTTAC-CTTCCTC). In each direction, the 59-most primer (3 or 6) and oligonucleotides coding for four restriction sites (BamHI, EcoRI, Sau3AI, and TaqI) were used as primers in the amplification of flanking RNR DNA using E. cloacae genomic DNA as the template. The PCR products were purified using the Qiagen PCR purification kit and used as a template in a nested PCR with the mixed restriction site primers and the internal specific primer (4 or 7) . Reaction products were gel-purified and sequenced in duplicate by direct automated sequencing using the 39-most oligonucleotide (5 or 8) as the sequencing primer. Thus, we have determined the complete DNA sequence of RNR.
RNR expression and purification
The RNR gene was PCR-amplified from Enterobacter chromosomal DNA using the oligonucleotides GCGCCCATGGATATCATTC-GTTGCCC and GCTCGAGTCAGCACTCG-GTCACAATCG, which correspond to the beginning and end of the RNR sequence determined above, with the addition of NcoI and XhoI restriction sites. The amplified gene was digested with NcoI and XhoI, gel-purified, and ligated into the NcoI and XhoI restriction sites of pET24d (Novagen) and transformed into E. coli strain DH5a. Successful transformants were grown overnight in 100 ml of LB containing 25 mg/ml kanamycin, plasmid DNA was isolated using the plasmid midi kit from Qiagen, and both strands of the insert were sequenced. The resulting plasmid, pRKRNR, was transformed into E. coli strain BL21(DE3) for expression. RNR was expressed and purified using the protocol originally described for NR (13) . Elution profiles from the preparative Sephadex G-100 chromatography column indicated that the protein was in a mixture of oligomeric states in very slow equilibrium. Native polyacrylamide gel electrophoretic (PAGE) analysis and sodium dodecyl sulfate (SDS)-PAGE analysis indicated that oligomers were formed by disulfide crosslinks. Only the fraction containing noncovalently bound homodimeric RNR (eluting last) was used in activity assays, and the protein was stored in 50 mM potassium phosphate buffer, pH 7.0, containing 1 mM b-mercaptoethanol. Purified protein concentrations were determined using e 280 5 54.5 mM 21 cm 21 (13) .
Activity assays
The specific activity of RNR was determined as described previously (13) by measuring the initial rate of NADH oxidation via the decrease in absorbance at 370 nm (e 5 2,660 M 21 cm 21 , in order to avoid nonlinear responses at high NADH concentrations) using a Hewlett-Packard 8453 spectrophotometer. All reactions were performed in 1-ml cuvettes with a 0.4-cm optical path length, and the temperature was maintained at 25°C using thermospacers and a circulating water bath. Reaction mixtures containing 1.2 mM NADH, 2 mM 2,4-DNT, 100 mM piperazine-N,N9-bis(2-ethanesulfonic acid) (PIPES), 50 mM KCl, 5% ethanol, pH 7.0, were thermoequilibrated at 25°C for at least 10 min before the reaction was initiated with a small amount (,10 ml) of cold enzyme solution. Similarly, assays used to determine kinetic parameters used variable amounts of either NADH or DNBA at fixed concentrations of the other substrate in 100 mM PIPES, 50 mM KCl, 5% ethanol, pH 7.0. Initial velocity data were fit nonlinearly with Eq. 1 on a personal computer with a 400-MHz AMD K6-2 processor using GRAFIT (15) . Here S corresponds to the concentration of the varied substrate, E is the concentration of NR or RNR, and k cat and K M are the turnover number and the Michaelis constant of the enzyme, respectively:
RESULTS
Sequence of RNR
The nucleotide sequence of RNR differs from that of NR in 64 codons, with no insertions or deletions. The DNA sequence of the region coding for RNR has been deposited in Genbank (accession no. AY013713). Despite the fact that nearly 30% of the codons in the RNR gene are different, the RNR amino acid sequence differs at only seven positions, a 96.7% identity with NR. Furthermore, with one exception, these differences are very conservative (see Fig. 3 ).
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Conserved residues in the NR gene family appear in white on a dark background on the NR sequence: residues that were shown in the crystal structure of NR to interact directly with the FMN cofactor are outlined in black. Other conserved residues appear on a gray background. Amino acid differences between NR and RNR are indicated with stars.
Expression and purification of RNR
The gene encoding RNR was cloned into the pET24d expression vector and transformed into E. coli strain BL21(DE3), which contains a chromosomal copy of the T7 polymerase gene behind a lac promoter. This allowed the IPTGinduced overexpression of RNR, evinced by the appearance of a single major band on a SDS-PAGE gel corresponding to a 23-kDa protein not detectable before induction (data not shown). RNR was purified by the methodology previously described for NR (13) , and behaved identically to NR throughout the purification, with the exception that the protein resolved into three bands on the final size exclusion column. SDS-PAGE and native PAGE analysis of each fraction indicated that they were disulfide-crosslinked oligomers of the RNR homodimer. Fractions containing pure homodimeric RNR that was not crosslinked were combined and used in the kinetic analysis. The final yield of purified RNR was 23.4 mg per liter of growth medium as determined spectrophotometrically.
Catalytic activity of RNR
The specific activity of purified RNR, using the previously published assay, is 190 6 10 units mg 21 , 45% of that determined for NR (13) . NR has been determined to catalyze electrontransfer reactions via a ping-pong mechanism (14) ; thus, the interaction between NR or RNR and their substrates can be viewed as two sequential simple binary reactions (termed halfreactions): the first between oxidized enzyme and NADH, and the second between the reduced enzyme and an electron acceptor. The catalytic efficiency of each enzyme in each halfreaction was determined using variable concentrations of either NADH or DNBA at the highest possible concentrations of the other substrate. DNBA is a new model compound that avoids the solubility problems encountered earlier with DNT and does not inhibit either enzymatic half-reaction at saturating concentrations. These kinetic parameters are summarized in Table 1 . RNR has the same catalytic efficiency, within error, as NR for the oxidizing substrate DNBA. For the reducing substrate NADH, however, RNR has a k cat /K M approximately half that of NR. Thus, the somewhat lower specific activity of RNR can be attributed to a decrease in the efficiency of NADH oxidation and not to any change in the enzyme's interaction with nitroaromatic compounds.
DISCUSSION
The physiological role of enteric nitroreductases has yet to be determined. As nitroaromatic compounds are not naturally occurring bacterial metabolites, nitroreductases must have some other as yet undiscovered function. Liochev et al. have shown the E. coli homologue of NR to be a member of the soxRS regulon, a family of oxidative defense enzymes (18) . They propose that nitroreductases reduce the pool of cytosolic quinones, as does eukaryotic DT diaphorase (NAD(P)H:quinone oxidoreductase, EC 1.6.99.2, ref. 6), thus protecting bacteria against the deleterious consequences of the redox cycling of quinones. Vasudevan et al. purified the E. coli nitroreductase as a dihydropteridine reductase, and propose that these enzymes are important in the biosynthesis of tetrahydrobiopterin (25, 26 real function of these bacterial enzymes, it seemed reasonable that NR was recruited from its original function and evolved into a more efficient nitroreductase due to the unusual nature of its proprietor bacterium's native environment. Inspection of the amino acid sequence of RNR and comparison of the two enzymes' activities and specificity belies this hypothesis. Although there is a statistically significant difference in activity, it is only twofold in magnitude, and this small dissimilarity is not large enough to have a substantial effect on nitroaromatic compound metabolism. Moreover, the affected half-reaction is the one pertaining to NADH oxidation and not nitroaromatic compound reduction. This increase in NR's activity is similar in magnitude to that seen in single rounds of directed evolution for changes in enzymatic activity or specificity (2, 10, 17) , but is much smaller than would be expected after many generations of selection if optimization of nitroreduction were truly beneficial.
Several aspects of the differences between NR and RNR are worthy of mention. The large number of differences between the two nucleotide sequences indicates that they are sufficiently separated evolutionarily for a large number of amino acid differences to exist. The small number of changes in the amino acid sequence of NR vs. RNR is thus somewhat surprising. Given the genetic diversity among related nitroreductases in general [as low as 40% sequence identity with NR (12)], it seems that the protein scaffold can accommodate a large number of changes with little change in oxidoreductase activity. It may be that the in vivo action of NR requires the formation of a complex with one or more other proteins, thereby necessitating the conservation of amino acids not involved in catalysis. The recently elucidated mechanism of action of Vibrio harveyi NADPH-FMN oxidoreductase, an NR homologue that forms a noncovalent complex with bacterial luciferase (16) , provides a precedent for this hypothesis.
RNR behaves differently from NR in only two significant ways: the aforementioned decrease in catalytic efficiency for NADH oxidation, and the presence of higher order enzyme oligomers in enzyme preparations. An unpublished crystal structure of NR has been available for some time (H.E. Hecht, unpublished data, PDB accession no. 1NEC), and an examination of this structure reveals a single amino acid substitution that may be responsible for both dissimilarities: a threonine to cysteine conversion at position 122 (see Fig. 4 ). This amino acid lies in an a helix that lies over the activesite cleft and is thought to be involved in substrate binding. This cysteine side chain is also solvent exposed and is likely the origin of the disulfide crosslink formation identified during the purification.
